AVITA Medical, Inc. Research And Development Expense

Quick Answer

AVITA Medical, Inc. reported Research And Development Expense of $20.84 million for the year ending 2025.

  • AVITA Medical, Inc. showed an increase of +2.4% in Research And Development Expense from 2024 to 2025.
  • This data is from AVITA Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), AVITA Medical, Inc.'s Research And Development Expense has grown by 233.1%.
  • Historical annual values: Fiscal year 2025: $20.84 million | Fiscal year 2024: $20.36 million | Fiscal year 2023: $20.82 million | Fiscal year 2022: $13.86 million | Fiscal year 2021: $14.82 million | Fiscal year 2020: $9.16 million | Fiscal year 2019: $8.00 million | Fiscal year 2018: $6.26 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: